Mindstate Design Labs
A clinical-stage AI neuroengineering platform and drug development company addressing the mental health crisis by creating a new way that we can change our minds.
About Mindstate Design Labs
We're making every therapeutically valuable emotion available on demand in pharmaceutical form.
Our Osmanthus platform is an ensemble of AI models that synthesize the world’s largest datasets of psychoactive pharmacology and phenomenology, quantitatively pinpointing the combination of neurotransmitter receptor activity that underlies various emotional as well as cognitive and perceptual states.
Our lead program MSD-001 is designed to be rapid-acting and produce heightened emotional and cognitive flexibility without hallucinations. MSD-001 is currently in human trials, and will be the base ingredient for multiple drug combination "emotions in a bottle" such as empathy, awe, clarity, or beauty.
Products
AI-powered discovery platform that maps the biological basis of emotion, perception, and cognition.
Security and compliance
No security details published yet
Mindstate Design Labs hasn't published certifications or security practices that we could find. Ask their team for audit reports.
Is this your company?
Claim the profile to keep facts current, answer buyers and submit evidence for the next ranking review.
Claim Mindstate Design Labs